This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBiogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, PAs, and patient advocates in the care of people living with multiple sclerosis (MS). Faculty Robert …
Category Archives: Webinar/Video
Building Clinical Confidence: Evidence-based Care for People Living with MS
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. Target Audience Neurologists, primary care physicians, nurse practitioners, nurses, physician assistants, rehabilitation specialists, mental health specialists, radiologists, and other clinicians who are part …
Continue reading “Building Clinical Confidence: Evidence-based Care for People Living with MS”
Contemporary Considerations in Multiple Sclerosis Treatment:
A Post-Pandemic Educational Curriculum
Release Date: January 10, 2023 Valid for Credit through: January 10, 2024 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants from Biogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, physician assistants, and …
Building Clinical Confidence: Evidence-based Care for People Living with MS
Released On: December 5, 2022 Expires On: December 5, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. This activity can take up to 75 minutes to complete. Target Audience Neurologists, primary …
Continue reading “Building Clinical Confidence: Evidence-based Care for People Living with MS”
Collaborating Across the Continuum™: Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy
Release Date: November 30, 2022 Expiration Date: November 30, 2023 Faculty: Stephen Krieger, MD, FAAN Jacci Bainbridge, PharmD, FCCP Denise Bruen, ANP-BC, MSN, MSCN Activity Overview Following the success of anti-CD20 antibodies in the treatment of multiple sclerosis (MS), there has been a shift in understanding of its pathophysiology. B cells have been identified as …
What Would You Do? An Interactive and Evidence-Based Educational Session on MS Treatment Approaches
Release Date: December 13, 2022 Valid for Credit through: December 13, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBiogen and Genentech. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — maximum of 1.0 contact …
Preventing Common Secondary Conditions in Advanced MS: A Focus on Urinary Tract Infections
Target Audience This activity has been designed to meet the educational needs of nursing professionals, physicians, advanced practice clinicians, social workers, and other members of the healthcare team involved in the management of patients with MS. Learning Objectives Upon completing this activity, participants should be better able to: Identify modifiable risk factors of urinary tract …
Evolution of Progression: An Expert Forum on Advancement in Monitoring and Treating Multiple Sclerosis
Release Date: 11/3/22 Expiration Date: 11/3/23 Activity Overview Advancements in the understanding of the pathophysiological mechanisms underlying multiple sclerosis (MS) have surged in recent years including increasing recognition that brain damage and subsequent disease worsening may occur earlier and more subtly than previously recognized. To date, there is no consensus regarding the relative roles of …
Neuromyelitis Optica Spectrum Disorder: Novel Therapeutic Landscape and Impact on Treatment Paradigms
Release Date: 7/28/2022Expiration Date: 7/27/2023 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. There is no non-commercial support for this activity. Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will …
The Changing Face of Multiple Sclerosis: Addressing the Demographic Shift Towards Elderly Patients
Release Date: 7/18/2022Expiration Date: 7/17/2023 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from EMD Serono, Inc. There is no non-commercial support for this activity. Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be …